| Normal tissues | Malignant tissues | Benign tissues |
---|---|---|---|
Age (years) | Â | Â | Â |
≤ 30 | 2 | 0 | 4 |
30–50 | 14 | 14 | 5 |
50–70 | 2 | 9 | 1 |
≥ 70 | 1 | 8 | 0 |
Menstrual status | Â | Â | Â |
Premenopausal | 17 | 15 | 7 |
Postmenopausal | 2 | 16 | 3 |
Tumor size (cm) | Â | Â | Â |
≤ 2 | − | 4 | 1 |
2–5 | − | 20 | 7 |
≥ 5 | − | 7 | 1 |
Histologic Grading | Â | Â | Â |
(Bloom and Richardson) | Â | Â | Â |
G1 | − | 6 | − |
G 2 | − | 12 | − |
G 3 | − | 8 | − |
Pathologic staging | Â | Â | Â |
I | − | 0 | − |
II | − | 10 | − |
III | − | 9 | − |
IV | − | 1 | − |
Lymph nodes | Â | Â | Â |
Negative | − | 11 | − |
1–3 | – | 4 | – |
≥ 3 | – | 15 | – |
Death | Â | Â | Â |
Yes | 0 | 10 | 0 |
No | 19 | 21 | 9 |
Estrogen receptor | Â | Â | Â |
Negative | – | 12 | – |
Positive | – | 21 | – |
Progesterone receptor | Â | Â | Â |
Negative | – | 13 | – |
Positive | – | 20 | – |
HER2 | Â | Â | Â |
0 | – | 12 | – |
1+ | – | 7 | – |
2+ | – | 8 | – |
3+ | – | 6 | – |